239 related articles for article (PubMed ID: 35652154)
1. Prognostic and clinicopathological significance of cytocapsular tubes in oral squamous cell carcinoma.
Wang W; Xie N; Yi C; Zhang M; Xiong G; Xu X; Hou J; Wang C
J Oral Pathol Med; 2022 Jul; 51(6):520-528. PubMed ID: 35652154
[TBL] [Abstract][Full Text] [Related]
2. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
3. [Expression of RACK1 and EGP40 in oral squamous cell carcinoma and its correlation with clinicopathological features and prognosis].
Duan YH; Wu KL; Mei J; Zhou YY; Liu MS
Shanghai Kou Qiang Yi Xue; 2023 Aug; 32(4):385-390. PubMed ID: 38044732
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance, prognostic value and biological role of lncRNA LINC01793 in oral squamous cell carcinoma.
Yuan SJ; Li SY; Wang YH; Zhang HF; Hua Y; Wang T
Arch Oral Biol; 2021 May; 125():105105. PubMed ID: 33713982
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
6. Prognostic evaluation of tumour budding in oral squamous cell carcinoma: Evidenced by CD44 expression as a cancer stem cell marker.
Niranjan KC; Raj M; Hallikeri K
Pathol Res Pract; 2023 Nov; 251():154883. PubMed ID: 37898041
[TBL] [Abstract][Full Text] [Related]
7. Improved recurrence rates and progression-free survival in primarily surgically treated oral squamous cell carcinoma - results from a German tertiary medical center.
Struckmeier AK; Buchbender M; Lutz R; Kesting M
Clin Oral Investig; 2024 Apr; 28(5):262. PubMed ID: 38642146
[TBL] [Abstract][Full Text] [Related]
8. Relationship of programmed death ligand-1 expression with clinicopathological features and prognosis in patients with oral squamous cell carcinoma: A meta-analysis.
He J; Chen XF; Xu MG; Zhao J
Arch Oral Biol; 2020 Jun; 114():104717. PubMed ID: 32344357
[TBL] [Abstract][Full Text] [Related]
9. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma.
Xie N; Wang C; Liu X; Li R; Hou J; Chen X; Huang H
J Oral Pathol Med; 2015 Apr; 44(4):266-72. PubMed ID: 25169851
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
[TBL] [Abstract][Full Text] [Related]
11. [Expression and clinical significance of BTG-1 in 78 patients with oral squamous cell carcinoma].
Jin NH; Nan XR; Yan XQ
Shanghai Kou Qiang Yi Xue; 2021 Apr; 30(2):140-144. PubMed ID: 34109351
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of tumor-infiltrating immune cells in clinical early-stage oral squamous cell carcinoma.
Huang Z; Lu Y; Wang W; Xie N; Yi C; Xiong G; Xu X; Zhang M; Wang C
J Oral Pathol Med; 2023 May; 52(5):372-380. PubMed ID: 36135715
[TBL] [Abstract][Full Text] [Related]
13. Lymphatic Vascular Density, the Expression of Podoplanin and Tumor Budding in Oral Squamous Cell Carcinoma.
de Assis EM; Rodrigues M; Vieira JC; Pascoaloti MIM; Junior HM; Souto GR; Souza PEA; Horta MCR
Head Neck Pathol; 2023 Jun; 17(2):371-382. PubMed ID: 36480090
[TBL] [Abstract][Full Text] [Related]
14. Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma.
Wei H; Yu K; Liu Y; Li L; Wang G
BMC Cancer; 2020 Aug; 20(1):756. PubMed ID: 32787801
[TBL] [Abstract][Full Text] [Related]
15. Prognostic effect of surgical treatment in elderly oral squamous cell carcinoma patients: A retrospective study.
Zhi Y; Li S; Li Y; Ren W; Gao L; Zhi K
Oral Oncol; 2024 Jul; 154():106849. PubMed ID: 38749112
[TBL] [Abstract][Full Text] [Related]
16. [Expression and prognostic value of IL-6 and β-catenin in oral squamous cell carcinoma].
Dong LS; Tang J; Cheng W; Ran JX; Liu ZB; Li YD
Shanghai Kou Qiang Yi Xue; 2023 Jun; 32(3):280-286. PubMed ID: 37803984
[TBL] [Abstract][Full Text] [Related]
17. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of RKIP, TGM2, and CMTM4 expression in oral squamous cell carcinoma.
Luo T; Xu T; Ou Y; Ci H; Sun J
Medicine (Baltimore); 2024 Feb; 103(7):e37278. PubMed ID: 38363884
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of clinicopathological parameters and outcome in 484 patients with oral squamous cell carcinoma: microvascular invasion (V+) is an independent prognostic factor for OSCC.
Grimm M
Clin Transl Oncol; 2012 Nov; 14(11):870-80. PubMed ID: 22855158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
